Charlotte H P Cremers1,2, Ivo A C van der Bilt3, Irene C van der Schaaf4, Mervyn D I Vergouwen5, Jan Willem Dankbaar4, Maarten J Cramer6, Arthur A M Wilde3, Gabriel J E Rinkel5, Birgitta K Velthuis4. 1. Department of Neurology and Neurosurgery, Room G03.232, Brain Center Rudolf Magnus, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. c.h.p.Cremers-2@umcutrecht.nl. 2. Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands. c.h.p.Cremers-2@umcutrecht.nl. 3. Heart Center, Department of Clinical and Experimental Cardiology, Academic Medical Center, Amsterdam, The Netherlands. 4. Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands. 5. Department of Neurology and Neurosurgery, Room G03.232, Brain Center Rudolf Magnus, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. 6. Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Abstract
INTRODUCTION: Cardiac dysfunction may occur after aneurysmal subarachnoid hemorrhage (aSAH). Although it is associated with poor outcome, the pathophysiological mechanism of this association remains unclear. We investigated the relationship between cardiac function and cerebral perfusion in patients with aSAH. METHODS: We studied 72 aSAH patients admitted within 72 h after ictus with echocardiography and cerebral CT perfusion within 24 h after admission. Cardiac dysfunction was defined as myocardial wall motion abnormalities or positive troponin. In patients with and without cardiac dysfunction, we calculated the mean perfusion [cerebral blood flow (CBF) and time-to-peak (TTP)] in standard regions of interest and calculated differences with 95% confidence intervals (95% CI). RESULTS: In 35 patients with cardiac dysfunction minimal CBF was 15.83 mL/100 g/min compared to 18.59 in 37 without (difference of means -2.76; 95% CI -5.43 to -0.09). Maximal TTP was 26.94 s for patients with and 23.10 s for patients without cardiac dysfunction (difference of means 3.84; 95% CI 1.63-6.05). Mean global CBF was 21.71 mL/100 g/min for patients with cardiac dysfunction and 24.67 mL/100 g/min for patients without cardiac dysfunction (-2.96; 95% CI -6.19 to 0.27). Mean global TTP was 25.27 s for patients with cardiac dysfunction and 21.26 for patients without cardiac dysfunction (4.01; 95% CI 1.95-6.07). CONCLUSION: aSAH patients with cardiac dysfunction have decreased focal and global cerebral perfusion. Further studies should evaluate whether this relation is explained by a direct effect of cardiac dysfunction on cerebral circulation or by an external determinant, such as a hypercatecholaminergic or hypometabolic state, influencing both cardiac function and cerebral perfusion.
INTRODUCTION:Cardiac dysfunction may occur after aneurysmal subarachnoid hemorrhage (aSAH). Although it is associated with poor outcome, the pathophysiological mechanism of this association remains unclear. We investigated the relationship between cardiac function and cerebral perfusion in patients with aSAH. METHODS: We studied 72 aSAH patients admitted within 72 h after ictus with echocardiography and cerebral CT perfusion within 24 h after admission. Cardiac dysfunction was defined as myocardial wall motion abnormalities or positive troponin. In patients with and without cardiac dysfunction, we calculated the mean perfusion [cerebral blood flow (CBF) and time-to-peak (TTP)] in standard regions of interest and calculated differences with 95% confidence intervals (95% CI). RESULTS: In 35 patients with cardiac dysfunction minimal CBF was 15.83 mL/100 g/min compared to 18.59 in 37 without (difference of means -2.76; 95% CI -5.43 to -0.09). Maximal TTP was 26.94 s for patients with and 23.10 s for patients without cardiac dysfunction (difference of means 3.84; 95% CI 1.63-6.05). Mean global CBF was 21.71 mL/100 g/min for patients with cardiac dysfunction and 24.67 mL/100 g/min for patients without cardiac dysfunction (-2.96; 95% CI -6.19 to 0.27). Mean global TTP was 25.27 s for patients with cardiac dysfunction and 21.26 for patients without cardiac dysfunction (4.01; 95% CI 1.95-6.07). CONCLUSION: aSAH patients with cardiac dysfunction have decreased focal and global cerebral perfusion. Further studies should evaluate whether this relation is explained by a direct effect of cardiac dysfunction on cerebral circulation or by an external determinant, such as a hypercatecholaminergic or hypometabolic state, influencing both cardiac function and cerebral perfusion.
Authors: Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani Journal: Circulation Date: 2002-01-29 Impact factor: 29.690
Authors: Ilan S Wittstein; David R Thiemann; Joao A C Lima; Kenneth L Baughman; Steven P Schulman; Gary Gerstenblith; Katherine C Wu; Jeffrey J Rade; Trinity J Bivalacqua; Hunter C Champion Journal: N Engl J Med Date: 2005-02-10 Impact factor: 91.245
Authors: Ivo van der Bilt; Djo Hasan; Renee van den Brink; Maarten-Jan Cramer; Mathieu van der Jagt; Fop van Kooten; John Meertens; Maarten van den Berg; Rob Groen; Folkert Ten Cate; Otto Kamp; Marco Götte; Janneke Horn; Johan Groeneveld; Peter Vandertop; Ale Algra; Frans Visser; Arthur Wilde; Gabriel Rinkel Journal: Neurology Date: 2013-12-20 Impact factor: 9.910
Authors: Maria E Baldwin; R Loch Macdonald; Dezheng Huo; Roberta L Novakovic; Roberta L Novakovia; Fernando D Goldenberg; Jeffrey I Frank; Axel J Rosengart Journal: Stroke Date: 2004-10-07 Impact factor: 7.914
Authors: Amber McAteer; Marilyn Hravnak; Yuefang Chang; Elizabeth A Crago; Matthew J Gallek; Khalil M Yousef Journal: Biol Res Nurs Date: 2017-06-19 Impact factor: 2.522
Authors: Susan Marzolini; Andrew D Robertson; Paul Oh; Jack M Goodman; Dale Corbett; Xiaowei Du; Bradley J MacIntosh Journal: Front Neurol Date: 2019-11-15 Impact factor: 4.003